{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:17:06Z","timestamp":1793236626765,"version":"4.5.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006090","name":"EU Global Health","doi-asserted-by":"publisher","award":["101159438"],"award-info":[{"award-number":["101159438"]}],"id":[{"id":"10.13039\/100006090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cryptosporidiosis is a major cause of parasitic diarrhea in lower-income countries disproportionately affecting young children, malnourished populations, and people with compromised immunity. While still underemphasized on the global health agenda, the disease is gradually gaining momentum for therapeutic development. However, the real-world impact of any new medicine will hinge on its effective use in regions that currently face significant access barriers. This Perspective asks what it will take to achieve access to new cryptosporidiosis treatments and outlines strategies to bridge scientific progress with real-world delivery.<\/jats:p>","DOI":"10.1093\/infdis\/jiag226","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:49:39Z","timestamp":1776430179000},"source":"Crossref","is-referenced-by-count":1,"title":["Proactive Access Strategies for Novel Cryptosporidiosis Therapeutics"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-8933","authenticated-orcid":false,"given":"Jonathan","family":"Spector","sequence":"first","affiliation":[{"name":"Global Health, Biomedical Research, Novartis , Cambridge, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-2326","authenticated-orcid":false,"given":"Kurt","family":"Hanevik","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Faculty of Medicine, University of Bergen , Bergen ,","place":["Norway"]},{"name":"Department of Medicine, National Center for Tropical Infectious Diseases, Haukeland University Hospital , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2008-0912","authenticated-orcid":false,"given":"Poonum S","family":"Korpe","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-9303","authenticated-orcid":false,"given":"Ujjini H","family":"Manjunatha","sequence":"additional","affiliation":[{"name":"Global Health, Biomedical Research, Novartis , Emeryville, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0990-4748","authenticated-orcid":false,"given":"Bridget D","family":"Stuart","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis , Cambridge, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8221-6785","authenticated-orcid":false,"given":"Paul","family":"Ashigbie","sequence":"additional","affiliation":[{"name":"Global Health, Biomedical Research, Novartis , Cambridge, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Amadi","sequence":"additional","affiliation":[{"name":"Tropical Gastroenterology and Nutrition Group, University of Zambia School of Medicine , Lusaka ,","place":["Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0844-6448","authenticated-orcid":false,"given":"Paul","family":"Kelly","sequence":"additional","affiliation":[{"name":"Tropical Gastroenterology and Nutrition Group, University of Zambia School of Medicine , Lusaka ,","place":["Zambia"]},{"name":"Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London , London, England ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2026043014482510400_jiag226-B1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"2026043014482510400_jiag226-B2","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1016\/S2214-109X(19)30076-2","article-title":"The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the global enteric multicenter study (GEMS)","volume":"7","author":"Kotloff","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2026043014482510400_jiag226-B3","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2214-109X(18)30283-3","article-title":"Morbidity, mortality, and long-term consequences associated with diarrhoea from cryptosporidium infection in children younger than 5 years: a meta-analyses study","volume":"6","author":"Khalil","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2026043014482510400_jiag226-B4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(24)00691-1","article-title":"Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990-2021, for 204 countries and territories: a systematic analysis for the global burden of disease study 2021","volume":"25","author":"Collaborators GBDDD","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026043014482510400_jiag226-B5","author":"Institute for Health Metrics and Evaluation (IHME)"},{"key":"2026043014482510400_jiag226-B6","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/cid\/ciy355","article-title":"Epidemiology and risk factors for cryptosporidiosis in children from eight low-income sites: results from the MAL-ED study","volume":"67","author":"Korpe","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026043014482510400_jiag226-B7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/oxfordjournals.aje.a009675","article-title":"Effects of cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth","volume":"148","author":"Checkley","year":"1998","journal-title":"Am J Epidemiol"},{"key":"2026043014482510400_jiag226-B8","doi-asserted-by":"crossref","first-page":"e1319","DOI":"10.1016\/S2214-109X(18)30351-6","article-title":"Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study","volume":"6","author":"Rogawski","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2026043014482510400_jiag226-B9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4269\/ajtmh.2002.66.590","article-title":"Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown","volume":"66","author":"Niehaus","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"2026043014482510400_jiag226-B10","doi-asserted-by":"crossref","first-page":"e012540","DOI":"10.1136\/bmjgh-2023-012540","article-title":"Safe and effective treatments are needed for cryptosporidiosis, a truly neglected tropical disease","volume":"8","author":"Gilbert","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2026043014482510400_jiag226-B11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1377\/hlthaff.28.4.962","article-title":"Creating access to health technologies in poor countries","volume":"28","author":"Frost","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"2026043014482510400_jiag226-B12","author":"Chen"},{"key":"2026043014482510400_jiag226-B13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"key":"2026043014482510400_jiag226-B14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2334-9-195","article-title":"High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial","volume":"9","author":"Amadi","year":"2009","journal-title":"BMC Infect Dis"},{"key":"2026043014482510400_jiag226-B15","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/s41564-024-01810-x","article-title":"Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis","volume":"9","author":"Manjunatha","year":"2024","journal-title":"Nature Microbiology"},{"key":"2026043014482510400_jiag226-B16","doi-asserted-by":"crossref","first-page":"e166814","DOI":"10.1172\/JCI166814","article-title":"Specific cryptosporidium antigens associate with reinfection immunity and protection from cryptosporidiosis","volume":"133","author":"Gilchrist","year":"2023","journal-title":"J Clin Invest"},{"key":"2026043014482510400_jiag226-B17","author":"Foundation AtM"},{"key":"2026043014482510400_jiag226-B18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2026043014482510400_jiag226-B19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cmi.2025.12.021","article-title":"Evaluation of rectal swab compared to bulk stool sampling for detection of cryptosporidium infection by light-emitting diode auramine-phenol microscopy in young children with diarrhoea","volume":"32","author":"Abate","year":"2026","journal-title":"Clin Microbiol Infect"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag226\/68115797\/jiag226.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag226\/68115797\/jiag226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:48:33Z","timestamp":1777574913000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiag226\/8659280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag226","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"jiag226"}}